Kisunla 350 mg
Kisunla 350 mg is a medicine authorised by Swissmedic under authorisation number 69523. The authorisation holder is Eli Lilly (Suisse) SA. The medicinal product code is Biotechnological medicines and the dispensing category is A: Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly. First authorisation was granted on 22 January 2026 and the authorisation is limited until 21 January 2031. ATC code N06DX05 places the medicine in the group Psychoanaleptics.
| Authorisation number | 69523 |
|---|---|
| Name | Kisunla 350 mg |
| Full name | Kisunla 350 mg, Konzentrat zur Herstellung einer Infusionslösung |
| Authorisation holder | Eli Lilly (Suisse) SA |
| Medicinal product code | Biotechnological medicines |
| Dispensing category | A · Prescription, not repeatable |
| ATC code | N06DX05 |
| First authorisation | 22 January 2026 |
| Authorisation validity | 21 January 2031 |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 1 | Kisunla 350 mg, Konzentrat zur Herstellung einer Infusionslösung | A | 22 January 2026 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 1 | 1 | Durchstechflasche(n) | N06DX05 | 01.99.0. | A |
Scroll the table sideways
Other medicines from this authorisation holder
Frequently asked questions
Is Kisunla 350 mg authorised in Switzerland?
Yes. Kisunla 350 mg is authorised by Swissmedic under authorisation number 69523, data as of 01 September 2026. The authorisation is limited until 21 January 2031.
Which dispensing category does Kisunla 350 mg have?
Kisunla 350 mg is in dispensing category A. Supplied only against a medical or veterinary prescription that may not be dispensed repeatedly.
Who is the authorisation holder of Kisunla 350 mg?
The authorisation holder is Eli Lilly (Suisse) SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.